Capital Public Radio, Inc.7055 Folsom BoulevardSacramento,
(916) 278-8900(877) 480-5900
90.9 FM Sacramento
90.5 FM Tahoe/Reno
91.3 FM Stockton/Modesto
88.1 FM Quincy
88.9 FM Sacramento
91.7 FM Groveland/Sonora
88.7 FM Sutter/Yuba City
Science, technology, environment and health news and discussion with host Ira Flatow.
Friday 11 a.m. – 1 p.m and 9 p.m. – 11 p.mon News Station
A 39-year-old woman, the first participant enrolled in the Phase 1 clinical trial VRC 207, received a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Maryland, on September 2, 2014.
Photo courtesy of NIAID
Ebola Vaccines Fast-Tracked As Outbreak Slows
Could This 3-D Printer Print Itself?
Scientists Sniff Smelly Comet
Countering Memory Loss With Cocoa Compounds
Creature Double Feature
Doctors ‘Unwrap’ a 3,000-Year-Old Mummy
A Haunted House Turned Scientists’ Lab
Behind the Monster Music: Why Some Tunes Scare Us